Furthermore, elevated DHHC9 expression was significantly associated with poor clinical outcomes in colorectal cancer, lung adenocarcinoma, gastric cancer, pancreatic cancer and rectal adenocarcinoma (Figure 1H). The gene discussed is ZDHHC9; the disease is lung adenocarcinoma.